Zacks Investment Research
19 Jun 2026, 13:40 UTC · 1h ago
CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
19 Jun 2026, 13:40 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Cardinal Health reported 35% earnings per share (EPS) growth in its fiscal third-quarter 2026 and raised its earnings guidance. — Strong earnings growth combined with upward guidance typically triggers positive price action and signals operational strength.
+0.60Cardinal Health's specialty pharmaceutical revenues are expected to exceed $50 billion in fiscal 2026. — Clear revenue targets in a high-growth segment provide a tangible catalyst for future valuation increases.
+0.40Cardinal Health's Pharmaceutical and Specialty Solutions segment saw revenues rise 11% to $56.1 billion with an 18% jump in profit. — Profit growth outpacing revenue growth indicates expanding margins and improved operational efficiency.
+0.30Which stocks this story touches
Continue reading
6 related stories
Search tags
The company reported 35% EPS growth, raised earnings guidance, and is seeing strong expansion in its specialty pharmaceutical business.
The company is noted as being outperformed by Cardinal Health in the current year.
The company's shares have lost 8.5% year to date and it is being outperformed by its peer Cardinal Health.
[mutual] Cardinal Health and Cencora are identified as closest peers in the pharmaceutical distribution industry.
[mutual] Cardinal Health and McKesson are identified as closest peers in the pharmaceutical distribution industry.
[mutual] McKesson and Cencora are listed together as the primary peer group for Cardinal Health.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Proactive Investors
1h ago
